Study identifier:NIS-RSE-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Retrospective Epidemiological Study to map out patients with Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD health care in Real-Life Primary Care during the first ten years of the 21th century
Chronic Obstructive Pulmonary Disease
-
No
-
All
27394
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2014 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.
Location
Location
Uppsala, Sweden
Arms | Assigned Interventions |
---|---|
1 Primary care patients with COPD diagnosis | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.